Goal: The program seeks to prepare health care professionals who prescribe opioids, including ER/LA opioids, to fully assess patients before prescribing them, prescribe them carefully and safely, and to continue to monitor patients for early detection and prevention of serious adverse events. Through the use of this program, the learner will become familiar with general and specific drug information on ER/LA opioid analgesics, such as instructions for use, special precautions, adverse effects/side effects, drug interactions, opioid tolerance, risk of overdose, conversion methods, product safety, dosing, and effect of tolerance.
After completing this activity participants will be able to:
- Assess for risk of substance use disorders in patients being considered for treatment with ER/LA opioids
- Become knowledgeable about the general and specific characteristics of ER/LA opioids including the effect of tolerance on prescribing for patients
- Safely and effectively initiate treatment using these medications when it is indicated, based on a complete history and physical examination and assessment of pain and functioning of patients
- Use effective communication techniques with these patients and their caregivers to support the safe use and help prevent adverse effects and diversion
- Monitor patients on chronic opioid therapy, make appropriate referrals and safely discontinue medication use when indicated
Modules in this Training Activity
- Opioids and Pain: Assessment and Treatment Planning Prior to Prescribing (ER/LA Opioids)
- Opioids and Pain: Understanding ER/LA Opioids
- Opioids and Pain: Weighing Risks and Benefits (ER/LA Opioids)
- Opioids and Pain: Initiating, Monitoring, and Terminating Opioid Treatment (ER/LA Opioids)
- Opioids and Pain: Identifying, Assessing and Responding to an Aberrant Behavior
Audience and Accreditation
Audience: Prescribers of ER/LA opioids and other health professionals who impact patients taking these medications
|AMA PRA Category 1 Credit(s)™||5 hr(s)||4/1/17||3/31/20|
Accreditation Statement: Clinical Tools, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit™ Designation Statement: Clinical Tools, Inc. designates this enduring material for a maximum of AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A letter of completion for up to 5 hour(s) is available for non-physicians.
A score of 70% on the post-test is required to complete the activity.
Initial development of this activity was supported by a grant from the National Institute on Drug Abuse (#1R44DA027245-01), a contract from the National Institute on Drug Abuse (#HHSN271200800012C).
Most Recent Reviews: SBIRT
CTI Content Review: Thurs, 1/5/2017
CTI Editorial Review: Mon, 1/9/2017